Coral Gables, FL, United States of America

Neil William Flanzraich

This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Alzheon, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil William Flanzraich. Retrieved from https://idiyas.com/inventor/neil-william-flanzraich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neil William Flanzraich: Innovator in Neurodegenerative Disorder Treatments

Introduction

Neil William Flanzraich is a notable inventor based in Coral Gables, Florida. He has made significant contributions to the field of neurodegenerative disorders, particularly in the treatment of Alzheimer's disease. His innovative approach has led to the development of a patent that addresses critical health challenges faced by many individuals.

Latest Patents

Flanzraich holds a patent for "Methods for treating neurodegenerative disorders." This patent specifically focuses on Tramiprosate and its derivatives, which are designed to treat neurodegenerative disorders such as Alzheimer's disease. This advancement represents a crucial step in the ongoing battle against these debilitating conditions.

Career Highlights

Flanzraich is associated with Alzheon, Inc., a company dedicated to developing therapies for Alzheimer's disease. His work at Alzheon has positioned him as a key player in the pharmaceutical industry, contributing to innovative solutions for complex health issues. His expertise and dedication have been instrumental in advancing research and development in this critical area.

Collaborations

Flanzraich has collaborated with notable professionals in his field, including John A. Hey and Petr Kocis. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately benefiting the research and development process.

Conclusion

Neil William Flanzraich's contributions to the treatment of neurodegenerative disorders highlight his commitment to improving patient outcomes. His innovative work and collaborations continue to pave the way for advancements in the field of Alzheimer's disease treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…